Search results for " market"
Article
Commercial Production of Gene Therapies Using Suspension or Adherent Cell Lines
By Alex Chatel and Jean-Christophe Drugmand
The gene therapy market is foreseen to reach over $3 billion and grow at a compound annual growth rate (CAGR) of 34% until 2023 (1, 2), which makes it o…
Article
The Outlook for CMO Outsourcing in 2019
Routine services and products with smaller markets will be outsourced more frequently, and products requiring novel bioprocessing, where expertise or capacity remain limited, will also be outsourced m…
Article
State of the Biopharmaceutical Industry: Lessons from 2018 Survey Data
…pment to attain a major role in manufacturing, including dominating the pre-commercial bioprocessing markets, while single-use technology is only just starting to be adopted for commercial scale biop…
Article
From Darwin to Recombinant Fc Multimers
IgG market will continue to dominate with 46% of market, followed by albumin, 18%, John Perkins stressed the importance of other plasma proteins to have a good process economy.
Some of the …
Article
Milestones and Moderate Progress in 2012 Drug Approvals
Twelve biopharmaceutical marketing applications were approved in the United States and/or the European Union in 2012 (see Table I). Approval numbers for the past year are in line with those recorded o…
Article
Maximizing the Effectiveness of Upstream Bioprocessing Through the Combination of Lab Informatics and Instrumentation
By Claire Hill
The biopharmaceutical market continues to expand at a rapid pace and the demand for upstream manufacturing capacity, particularly for growth areas such as viral vectors, is growing …
Article
ADC Development Robust Despite Lackluster Performance
The road to market has been difficult, however, with only three ADC products approved for sale by FDA in the United States as of October 2017. This has not stopped ADC developers, though, and the biop…
Article
Platform Technologies Improve Protein Expression
Challener
Speed to market is essential in the biopharmaceutical industry today. Manufacturers are seeking mechanisms for increasing efficiencies and reducing costs without compromising the…
Article
The New World of Biopharmaceutical Manufacturing
…r turnaround between products and batches, resulting in reduced capital costs and increased speed to market. Single-use technology has also precipitated changes in upstream and downstream processing.…
Article
Biosimilars to Drive Modern Manufacturing Approaches
By Jill Wechsler
As more biosimilars gain market approval in the United States, and manufacturers launch additional programs to develop competitive biotech therapies, regulatory authorities and in…